$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000121390021021736 Filed on April 15, 2021

Income Statement

Concept	2020 Q4	2020	2019 Q4
Revenue	$7.350M	$8.756M	$340.0K
YoY Change	2061.76%	193.34%	-84.96%
Cost Of Revenue	$5.750M	$6.535M	$290.0K
YoY Change	1882.76%	183.23%	-86.45%
Gross Profit	$1.610M	$2.220M	$50.00K
YoY Change	3120.0%	227.78%	-58.33%
Gross Profit Margin	21.9%	25.36%	14.71%
Selling, General & Admin	$3.070M	$271.0K	$1.080M
YoY Change	184.26%	-86.64%	-43.16%
% of Gross Profit	190.68%	12.21%	2160.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$90.00K	$50.66K	$40.00K
YoY Change	125.0%	426.5%	-75.0%
% of Gross Profit	5.59%	2.28%	80.0%
Operating Expenses	$3.070M	$6.803M	$1.080M
YoY Change	184.26%	-7.84%	-42.86%
Operating Profit	-$1.460M	-$4.583M	-$1.030M
YoY Change	41.75%	-31.64%	-41.81%
Interest Expense	$20.00K	$50.00K	-$180.0K
YoY Change	-111.11%	-127.78%
% of Operating Profit
Other Income/Expense, Net	$0.00	$74.67K	$10.00K
YoY Change	-100.0%	-134.49%
Pretax Income	-$1.440M	-$4.508M	-$4.130M
YoY Change	-65.13%	-34.86%	132.02%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$1.630M	-$4.693M	-$4.130M
YoY Change	-60.53%	-32.19%	125.68%
Net Earnings / Revenue	-22.18%	-53.6%	-1214.71%
Basic Earnings Per Share
Diluted Earnings Per Share	-$188.9K	-$786.9K	-$8.787M
COMMON SHARES
Basic Shares Outstanding	8.596M shares		6.008M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2020	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.01M	$13.01M	$1.630M
YoY Change	698.16%	698.16%	18.98%
Cash & Equivalents	$13.01M	$13.01M	$1.626M
Short-Term Investments
Other Short-Term Assets	$570.0K	$570.0K	$17.60M
YoY Change	-96.76%	714.29%	-81.99%
Inventory	$778.1K	$780.0K
Prepaid Expenses
Receivables	$2.636M	$3.940M	$1.101M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$18.30M	$18.30M	$2.907M
YoY Change	529.49%	528.87%	-33.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.683M	$4.220M	$11.75K
YoY Change	22739.99%	42100.0%	-83.53%
Goodwill	$1.309M		$1.224M
YoY Change	7.01%		-70.6%
Intangibles	$2.219M		$2.299M
YoY Change	-3.49%		-5.94%
Long-Term Investments
YoY Change
Other Assets	$150.0K	$150.0K	$190.0K
YoY Change	-21.05%	-21.05%
Total Long-Term Assets	$8.584M	$8.580M	$3.728M
YoY Change	130.27%	130.65%	-44.17%
TOTAL ASSETS
Total Short-Term Assets	$18.30M	$18.30M	$2.907M
Total Long-Term Assets	$8.584M	$8.580M	$3.728M
Total Assets	$26.88M	$26.88M	$6.635M
YoY Change	305.18%	305.43%	-39.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.012M	$3.960M	$2.110M
YoY Change	42.76%	87.68%	-19.47%
Accrued Expenses	$310.0K	$310.0K
YoY Change
Deferred Revenue	$1.775M		$169.0K
YoY Change	950.41%		-87.34%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$20.00K	$20.00K
YoY Change
Total Short-Term Liabilities	$7.235M	$7.230M	$2.274M
YoY Change	218.08%	218.5%	-42.55%
LONG-TERM LIABILITIES
Long-Term Debt	$30.00K	$30.00K	$0.00
YoY Change
Other Long-Term Liabilities	$1.180M	$1.180M
YoY Change
Total Long-Term Liabilities	$1.210M	$1.210M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.235M	$7.230M	$2.274M
Total Long-Term Liabilities	$1.210M	$1.210M	$0.00
Total Liabilities	$8.444M	$8.630M	$2.274M
YoY Change	271.26%	280.18%	-42.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.28M		-$17.58M
YoY Change	26.69%		64.9%
Common Stock	$85.96K		$11.58K
YoY Change	642.4%		443.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.25M	$18.25M	$4.360M
YoY Change
Total Liabilities & Shareholders Equity	$26.88M	$26.88M	$6.635M
YoY Change	305.18%	305.43%	-39.9%

Cashflow Statement

Concept	2020 Q4	2020	2019 Q4
OPERATING ACTIVITIES
Net Income	-$1.630M	-$4.693M	-$4.130M
YoY Change	-60.53%	-32.19%	125.68%
Depreciation, Depletion And Amortization	$90.00K	$50.66K	$40.00K
YoY Change	125.0%	426.5%	-75.0%
Cash From Operating Activities	$1.560M	-$2.888M	-$320.0K
YoY Change	-587.5%	2.57%	-79.22%
INVESTING ACTIVITIES
Capital Expenditures	-$1.520M	$1.568M	$0.00
YoY Change		75654.35%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$90.00K	-$1.480M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$1.610M	-$3.046M	$0.00
YoY Change		147036.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$17.32M	1.930M
YoY Change	-100.0%	463.2%
NET CHANGE
Cash From Operating Activities	1.560M	-$2.888M	-320.0K
Cash From Investing Activities	-1.610M	-$3.046M	0.000
Cash From Financing Activities	0.000	$17.32M	1.930M
Net Change In Cash	-50.00K	$11.38M	1.610M
YoY Change	-103.11%	4325.09%	-204.55%
FREE CASH FLOW
Cash From Operating Activities	$1.560M	-$2.888M	-$320.0K
Capital Expenditures	-$1.520M	$1.568M	$0.00
Free Cash Flow	$3.080M	-$4.456M	-$320.0K
YoY Change	-1062.5%	58.15%	-79.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q3	sgbx	Number Of Large Contracts NumberOfLargeContracts	2	Item
CY2019Q3	sgbx	Number Of Large Contracts NumberOfLargeContracts	2	Item
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2037-12-31
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	us-gaap	Bankruptcy Proceedings Description Of Proceedings BankruptcyProceedingsDescriptionOfProceedings	Intangible assets consist of $2,766,000 of proprietary knowledge and technology, which is being amortized over 20 years. In addition, included in intangible assets is $97,164 of trademarks, and $5,300 of website costs that are being amortized over 5 years.
CY2020	us-gaap	Operating Leases Indemnification Agreements Description OperatingLeasesIndemnificationAgreementsDescription	The leases have remaining lease terms of two and a half years to five years. The plant lease includes an option to extend the lease for up to five years.
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2020	sgbx	Warranty Offered On Completed Contracts WarrantyOfferedOnCompletedContracts	P1Y
CY2020	us-gaap	Restricted Cash And Cash Equivalent Item Description RestrictedCashAndCashEquivalentItemDescription	The event that the Agreement is earlier terminated, CMC will still be entitled to receive the entire amount of such restricted stock that has vested as of such earlier termination date, but in no event less than 1,250 shares of such restricted stock. The Agreement also provides for customary indemnification and confidentiality obligations between the parties. The 2,500 shares of restricted stock of the Company's common stock has yet to be issued to CMC.
CY2018Q1	sgbx	Options Vested Description OptionsVestedDescription	These options vest in equal quarterly installments over either a two-year and three-year period and will fully vest by the end of March 31, 2021.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date.
CY2020	sgbx	Operating Cycle Description OperatingCycleDescription	The length of the Company’s contracts varies, but is typically between six to twelve months.
CY2020Q4	sgbx	Number Of Large Contracts NumberOfLargeContracts	3	Item
CY2020	sgbx	License Consideration Description LicenseConsiderationDescription	In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) five percent (5%) on the first $20,000,000 of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) four and one-half percent (4.5%) on the next $30,000,000 of Gross Revenues, and (z) five percent (5%) on all Gross Revenues thereafter (collectively, the “Royalty”), subject to the following minimum royalty payments determined on a cumulative basis during the initial term: $500,000 in year 1, $750,000 in year 2, $500,000 in year 3, $2,000,000 in year 4, and $2,500,000 in year 5
CY2020	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	Item
CY2020Q1	sgbx	Description Of Claimed Amount DescriptionOfClaimedAmount	the Company and its Chairman and Chief Executive Officer, Paul Galvin, claiming (i) $372,638 in unpaid wages and bonuses and (ii) $300,000 due in severance
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	The restricted stock units granted on November 11, 2020 will vest 1/2 on November 11, 2020 and 1/2 on the one year anniversary of the grant date, subject to each individual’s continued service as a director of the Company through such date, and are payable six months after the termination of the director from the Company’s Board of Directors or death or disability. The fair value of these units upon issuance amounted to $111,920.
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Entity File Number EntityFileNumber	001-38037
CY2020	dei	Entity Registrant Name EntityRegistrantName	SG BLOCKS, INC.
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	<span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">17</span> State Street</span>,
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	<span style="border-left: none; border-right: none;">19</span>th Floor,
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10004
CY2020	dei	City Area Code CityAreaCode	(646)
CY2020	dei	Local Phone Number LocalPhoneNumber	240-4235
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2020	dei	Trading Symbol TradingSymbol	SGBX
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	dei	Entity Public Float EntityPublicFloat	22951825	USD
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8821289	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13010356	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2635608	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1101185	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1303136	USD
CY2019Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent		USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2218609	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1309330	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1223520	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1537545	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	682637	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2298805	USD
CY2020Q4	us-gaap	Deferred Costs DeferredCosts	152944	USD
CY2019Q4	us-gaap	Deferred Costs DeferredCosts	193730	USD
CY2020Q4	us-gaap	Assets Assets	26882098	USD
CY2019Q4	us-gaap	Assets Assets	6634611	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1774740	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	168957	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	326654	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	965561	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	106015	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	778144	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet		USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	570775	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73938	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	18298019	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	2906809	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2683014	USD
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		USD
CY2020Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	200765	USD
CY2019Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent		USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7234681	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2274462	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1209594	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		USD
CY2020Q4	us-gaap	Liabilities Liabilities	8444275	USD
CY2019Q4	us-gaap	Liabilities Liabilities	2274462	USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8596189	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8596189	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1157890	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1157890	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	85962	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	11579	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	184567	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest		USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18437823	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4360149	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26882098	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6634611	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-4582832	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-6704012	USD
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	9275	USD
CY2020	us-gaap	Revenues Revenues	8755623	USD
CY2019	us-gaap	Revenues Revenues	2984835	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	6535444	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	2307488	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40443840	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21932387	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22276546	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	18253256	USD
CY2020	us-gaap	Gross Profit GrossProfit	2220179	USD
CY2019	us-gaap	Gross Profit GrossProfit	677347	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2992207	USD
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2392587	USD
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3449849	USD
CY2019	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1788276	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	230248	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	240557	USD
CY2020	us-gaap	Other General Expense OtherGeneralExpense	130707	USD
CY2019	us-gaap	Other General Expense OtherGeneralExpense	21286	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2938653	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	6803011	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	7381359	USD
CY2019	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	178995	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	61675	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest		USD
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	23282	USD
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	14506	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1012	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-52039	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	74670	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-216528	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4508162	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6920540	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2020	us-gaap	Profit Loss ProfitLoss	-4508162	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-6920540	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	184567	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-6920540	USD
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.79
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5959403	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	302844	shares
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-699141	USD
CY2020	us-gaap	Depreciation Depreciation	50655	USD
CY2019	us-gaap	Depreciation Depreciation	9621	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7080067	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	946660	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	148541	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	145124	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	40786	USD
CY2019	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	10196	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	105770	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	73225	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10018	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-54000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	32637	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments		USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1261215	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	729404	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1012	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-52039	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	890531	USD
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	3253962	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-6920540	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4360149	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4360149	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1261215	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		USD
CY2020	sgbx	Stock Issued During Period Values Reverse Stock Splits StockIssuedDuringPeriodValuesReverseStockSplits	-122	USD
CY2020	sgbx	Conversion Of Debt Exchange Value ConversionOfDebtExchangeValue	206263	USD
CY2020	sgbx	Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts	17118480	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-4508162	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18437823	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-4508162	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-6920540	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2938653	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1166692	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-154310	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	647345	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	489437	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-912749	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-81256	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1129189	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-301457	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1236174	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1165930	USD
CY2020	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	965561	USD
CY2019	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	5000	USD
CY2019	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-82553	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-203926	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2887950	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2815621	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2020	us-gaap	Stock Issued1 StockIssued1		USD
CY2019	us-gaap	Stock Issued1 StockIssued1	217256	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1568115	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2070	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	743168	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		USD
CY2020	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	650000	USD
CY2019	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		USD
CY2020	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	84440	USD
CY2019	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture		USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3045723	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2070	USD
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	17118480	USD
CY2019	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3253962	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		USD
CY2019	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	375000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	USD
CY2020	sgbx	Settlement Of Common Stock From Reverse Stock Splits SettlementOfCommonStockFromReverseStockSplits	122	USD
CY2019	sgbx	Settlement Of Common Stock From Reverse Stock Splits SettlementOfCommonStockFromReverseStockSplits		USD
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
CY2019	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	480770	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	73225	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17318358	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3074967	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11384685	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	257276	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1368395	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13010356	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2614	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	105770	USD
CY2020	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	200000	USD
CY2019	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1		USD
CY2020	sgbx	Noncashconversionofinterestexpenseoflongtermdebt Noncashconversionofinterestexpenseoflongtermdebt	6263	USD
CY2019	sgbx	Noncashconversionofinterestexpenseoflongtermdebt Noncashconversionofinterestexpenseoflongtermdebt		USD
CY2020Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	<span style="border-left: none; border-right: none;">1</span>-for-<span style="border-left: none; border-right: none;">20</span>
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	25117461	USD
	sgbx	Proceeds From Public Offering ProceedsFromPublicOffering	1136015	USD
CY2019Q4	sgbx	Proceeds From Public Offering ProceedsFromPublicOffering	326000	USD
CY2020	sgbx	Proceeds From Public Offering ProceedsFromPublicOffering	2117948	USD
CY2020Q2	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	1522339	USD
CY2020Q2	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	15596141	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><b><i>Accounting estimates<span> </span></i></b>– The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, warrant liabilities and allowance for doubtful accounts. Actual results could differ from those estimates.</span></p> </div> </div> </div> </div> </div> </div>
CY2019Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.50	pure
CY2019Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	2500	shares
CY2020Q3	sgbx	Common Stock Vest And Be Issued Shares CommonStockVestAndBeIssuedShares	1250	shares
CY2020	sgbx	Residential Units ResidentialUnits	100	shares
CY2020	sgbx	Commercial Units CommercialUnits	1100	shares
CY2020	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	16900000	USD
CY2020Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	1	pure
CY2020	us-gaap	Related Party Costs RelatedPartyCosts	250000	USD
CY2020	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	2150323	USD
CY2020	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4057086	USD
CY2019	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4698537	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8755623	USD
CY2020	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2984835	USD
CY2019	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2020	sgbx	Construction Fee ConstructionFee	300000	USD
CY2020Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	306143	USD
CY2020Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	USD
CY2020Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50981	USD
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	965561	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13010356	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1625671	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2938653	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	649855	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	148541	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1614315	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	145124	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	158793	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	154470	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	152676	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	151969	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	148551	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1452150	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2218609	USD
CY2020	us-gaap	Depreciation Depreciation	50655	USD
CY2019	us-gaap	Depreciation Depreciation	9621	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.</span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At December 31, 2020 and 2019, 79% and <span style="border-left: none; border-right: none;">92</span>%, respectively, of the Company’s gross accounts receivable were due from three and one customers. </span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">Revenue relating to three and two customers represented approximately 61% and 78% of the Company’s total revenue for the years ended December 31, 2020 and 2019, respectively.</span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span><br/></span></span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span>For the year ended December 31, 2020, there were no vendors which represented 10% or more of our cost of revenue. For the year ended December 31, 2019, 74% of our cost of revenue related to three vendors</span>. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circ</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">umstances change with its existing suppliers.</span></p>
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3431522	USD
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1887080	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	795914	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	785895	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2635608	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1101185	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	795914	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10018	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-54000	USD
CY2020Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4572581	USD
CY2019Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	513558	USD
CY2020Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-872302	USD
CY2019Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-127032	USD
CY2020Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	5444883	USD
CY2019Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	640590	USD
CY2020Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	-5916487	USD
CY2019Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	-703532	USD
CY2020Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-471604	USD
CY2019Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-62942	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1303136	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	106015	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1774740	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	168957	USD
CY2020Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-471604	USD
CY2019Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-62942	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2741514	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20747	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58500	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2683014	USD
CY2020Q3	sgbx	Acquisition Cash AcquisitionCash	1059600	USD
CY2020Q4	us-gaap	Cash Cash	1059600	USD
CY2020Q4	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Earnoutliability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEarnoutliability		USD
CY2020Q4	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Settlement Of Accounts Receivable And Net Contract Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSettlementOfAccountsReceivableAndNetContractLiabilities	-94980	USD
CY2020	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	964620	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	316432	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	252557	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	130799	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	7400	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	1154818	USD
CY2020Q4	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Rightofuseassets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightofuseassets	57120	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	85810	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	68344	USD
CY2020Q4	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses	-733529	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	285204	USD
CY2020Q4	sgbx	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contractliabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractliabilities	-32807	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation	57120	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	964620	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
CY2019Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.22	pure
CY2020	sgbx	Percentage Of Exercise Price PercentageOfExercisePrice	0.09	pure
CY2020	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	5404	shares
CY2019Q4	sgbx	Commonstockascompensation Commonstockascompensation	5404	shares
CY2020Q4	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	1486067	USD
CY2020Q4	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	-307737	USD
CY2020Q4	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	-1178458	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1486195	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	51478	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	18917	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	31136	USD
CY2020Q4	sgbx	Total Finance Lease Liabilities TotalFinanceLeaseLiabilities	-50053	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	348117	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	20160	USD
CY2020Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	368277	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	348984	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	20160	USD
CY2020Q4	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	369144	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	330300	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	11760	USD
CY2020Q4	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	342060	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	324000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		USD
CY2020Q4	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	324000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	243000	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		USD
CY2020Q4	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	243000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1594401	USD
CY2020Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	52080	USD
CY2020Q4	us-gaap	Other Commitment OtherCommitment	1646481	USD
CY2020Q4	sgbx	Total Operating Imputed Interest TotalOperatingImputedInterest	108206	USD
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2027	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	110233	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1486195	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	50053	USD
CY2020Q4	sgbx	Presentvalueofleaseliabilities Presentvalueofleaseliabilities	1536248	USD
CY2020	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	1683000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses		pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.091	pure
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-828472	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-567767	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	564363	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1541948	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-264109	USD
CY2020	sgbx	Provision Income Tax Expense Benefit ProvisionIncomeTaxExpenseBenefit	-1541948	USD
CY2019	sgbx	Provision Income Tax Expense Benefit ProvisionIncomeTaxExpenseBenefit	-264109	USD
CY2020	sgbx	Amount Of Valuation Reserve AmountOfValuationReserve	1541948	USD
CY2020	sgbx	Differences Attributable To Change In State Business Apportionment DifferencesAttributableToChangeInStateBusinessApportionment		pure
CY2019	sgbx	Differences Attributable To Change In State Business Apportionment DifferencesAttributableToChangeInStateBusinessApportionment	-0.112	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.249	pure
CY2019	sgbx	Amount Of Valuation Reserve AmountOfValuationReserve	-264109	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.018	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4127323	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2857456	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	173840	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	800036	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	445799	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-529260	USD
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-502709	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-44979	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-850	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	47184	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	82628	USD
CY2020Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	205	USD
CY2019Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	181	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4598294	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3056345	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4598294	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3056345	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1541948	USD
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	16600000	USD
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5.5	USD
CY2020Q4	sgbx	Future Taxable Income Percentage FutureTaxableIncomePercentage	0.80	pure
CY2020Q4	sgbx	Future Taxable Income Temporarily Removes Percentage FutureTaxableIncomeTemporarilyRemovesPercentage	0.80	pure
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	17634261	USD
CY2018Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	97657379	USD
CY2020	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	13816785	USD
CY2019	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	17659053	USD
CY2020	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-27370	USD
CY2019	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	-94697336	USD
CY2020	sgbx	Construction Backlog Gross ConstructionBacklogGross	31423676	USD
CY2019	sgbx	Construction Backlog Gross ConstructionBacklogGross	20619096	USD
CY2019Q4	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	2117948	USD
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	440000	shares
CY2020Q2	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	1522339	USD
CY2019Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	17634261	USD
CY2020	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	17000000	USD
CY2019Q2	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	25000000	USD
CY2019Q4	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	2400000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	25117461	USD
CY2017Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	100.00
CY2017Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	176771	USD
CY2017Q3	sgbx	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	563	shares
CY2017Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	8321	shares
CY2020	sgbx	Contract Revenue ContractRevenue	6306215	USD
CY2019	sgbx	Contract Revenue ContractRevenue	2984835	USD
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	347661	USD
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6000000	shares
CY2020Q2	sgbx	Options Granted To Purchase Common Stock OptionsGrantedToPurchaseCommonStock	900000	shares
CY2020Q2	sgbx	Common Stock Exercise Price Per Share CommonStockExercisePricePerShare	0.01
CY2020Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	900000	shares
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6900000	shares
CY2020Q2	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	15596141	USD
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1653859	USD
CY2020Q2	sgbx	Common Stock Number Of Shares Underwritter CommonStockNumberOfSharesUnderwritter	300000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	45000	shares
CY2019Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17.00
CY2017Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-21
CY2019Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-10-29
CY2019Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-08-29
CY2020Q2	sgbx	Warrants To Purchase WarrantsToPurchase	300000	shares
CY2020Q2	us-gaap	Share Price SharePrice	3.14
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-05-05
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1261215	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	729404	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	55253	shares
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.80
CY2018Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	81.20
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y4M28D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2019	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2019	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2083	shares
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	53170	shares
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.80
CY2019Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	81.20
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2020	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
CY2020	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	16733	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36437	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
CY2020	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
CY2020Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	52649	shares
CY2019Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.80
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y4M20D
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36332	shares
CY2020Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10667	USD
CY2019Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	150580	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2667	USD
CY2020Q4	us-gaap	Share Price SharePrice	6.10
CY2019Q1	sgbx	Number Of Employees NumberOfEmployees	6	Employee
CY2019Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	9189	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	16.40
CY2020Q4	us-gaap	Share Price SharePrice	3.28
CY2019Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2100000	USD
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	USD
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	USD
CY2019Q2	sgbx	Unpaid Wages UnpaidWages	30428.71	USD
CY2020Q1	sgbx	Unpaid Wages UnpaidWages	372638	USD
CY2020Q1	sgbx	Severance Amount SeveranceAmount	300000	USD
CY2020Q2	sgbx	Severance Amount SeveranceAmount	300000	USD
CY2020Q2	us-gaap	Other Commitments Description OtherCommitmentsDescription	provide for an annual base salary of $400,000, provide for a performance bonus structure for a bonus of up to 50% of base salary upon the Company’s achievement of $2,000,000 EBITDA and additional performance bonus payments for the achievement of EBITDA in excess of $2,000,000 based on a percentage of the incremental increase in EBITDA (ranging from 10% of the incremental increase in EBITDA if the Company achieves over $2,000,000 and up to $7,000,000 in EBITDA, 8% of the incremental increase in EBITDA if the Company achieves over $7,000,000 and up to $12,000,000 in EBITDA and 3% of the incremental increase in EBITDA over $12,000,000), provide for a profits-based additional bonus of up to $250,000 in certain limited circumstances, and provide for one (1) year severance, plus a pro-rated amount of any unpaid bonus earned by him during the year as verified by the Company’s principal financial officer, if Mr. Galvin is terminated without cause. At the Company’s option, up to fifty (50%) percent of the EBITDA performance bonuses may be paid in restricted stock units if then available for grant under the Company’s Stock Incentive Plan. All other terms of the employment agreement remain in full force and effect.
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	703437	USD
CY2020Q4	us-gaap	Shares Issued SharesIssued	225100	shares

Files In Submission

Name	View Source	Status
0001213900-21-021736-index-headers.html	Edgar Link	pending
0001213900-21-021736-index.html	Edgar Link	pending
0001213900-21-021736.txt	Edgar Link	pending
0001213900-21-021736-xbrl.zip	Edgar Link	pending
ex211_2.htm	Edgar Link	pending
ex231_3.htm	Edgar Link	pending
ex311_4.htm	Edgar Link	pending
ex312_5.htm	Edgar Link	pending
ex321_6.htm	Edgar Link	pending
ex413_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20201231.htm	Edgar Link	pending
sgbx-20201231.xsd	Edgar Link	pending
sgbx-20201231_cal.xml	Edgar Link	unprocessable
sgbx-20201231_def.xml	Edgar Link	unprocessable
sgbx-20201231_htm.xml	Edgar Link	completed
sgbx-20201231_lab.xml	Edgar Link	unprocessable
sgbx-20201231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2020 Q4 Form 10-K Financial Statement

#000121390021021736 Filed on April 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2020 Q4 Form 10-K Financial Statement

#000121390021021736 Filed on April 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx